Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: an open-label Canadian trial (Q39327100)

11 September 2017

title

Transdermal fentanyl improves pain control and functionality in patients with osteoarthritis: an open-label Canadian trial (English)

1 reference

11 September 2017

0 references

0 references

Denis Choquette

1

1 reference

11 September 2017

Timothy G McCarthy

2

1 reference

11 September 2017

Jude F N Rodrigues

3

1 reference

11 September 2017

Allan J Kelly

4

1 reference

11 September 2017

Fernando Camacho

5

1 reference

11 September 2017

G L A Horbay

6

1 reference

11 September 2017

Farah A Husein-Bhabha

7

1 reference

11 September 2017

publication date

23 November 2007

1 reference

11 September 2017

published in

Clinical Rheumatology

1 reference

11 September 2017

volume

27

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

587-595

1 reference

Use of opioid analgesics for the treatment of chronic noncancer pain--a consensus statement and guidelines from the Canadian Pain Society, 2002.

11 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-007-0751-6

Commentary--goodbye M(C)ID! Hello MID, where do you come from?

21 January 2018

1 reference

12 December 2020

Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

1 reference

12 December 2020

Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial

1 reference

12 December 2020

Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study

1 reference

12 December 2020

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

1 reference

12 December 2020

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

12 December 2020

Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain.

1 reference

12 December 2020

Transdermal fentanyl as treatment for chronic low back pain

1 reference

12 December 2020

Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities

1 reference

12 December 2020

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee

1 reference

12 December 2020

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association

1 reference

12 December 2020

Fentanyl-TTS in the treatment of pain caused by arthrosis

1 reference

12 December 2020

Predictors for response to rehabilitation in patients with hip or knee osteoarthritis: a comparison of logistic regression models with three different definitions of responder

1 reference

12 December 2020

Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial

1 reference

12 December 2020

[Reduction in pain intensity after treatment for chronic back pain. When is it clinically meaningful?]

1 reference

12 December 2020

The Knee Clinical Assessment Study--CAS(K). A prospective study of knee pain and knee osteoarthritis in the general population

1 reference

12 December 2020

Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement

1 reference

12 December 2020

Clinically important outcomes in low back pain.

1 reference

12 December 2020

The clinical importance of changes in outcome scores after treatment for chronic low back pain

1 reference

12 December 2020

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee

1 reference

12 December 2020

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

12 December 2020

Use of the reliable change index to evaluate clinical significance in SF-36 outcomes.

1 reference

12 December 2020

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation

1 reference

12 December 2020

The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip.

1 reference

12 December 2020

10.1007/S10067-007-0751-6

Identifiers

DOI

1 reference

release_jk46ybbmf5f6rf74jyanhfty7a

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jk46ybbmf5f6rf74jyanhfty7a

24 November 2022

mapped directly with Wikidata item

1 reference